Clinical Study Of unani formulation and betamethsone in the treatment of Psoriasis.
Phase 2
- Conditions
- Health Condition 1: L409- Psoriasis, unspecified
- Registration Number
- CTRI/2020/07/026420
- Lead Sponsor
- central counsal for research in unani medicine new delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Clinically Diagnosed Patients of Psoriasis.
Patients irrespective of gender.
Patients in the age group of 10-60 years.
Clinically stable patients.
Patients who have agreed to sign the informed consent form and follow up the protocol.
Exclusion Criteria
Subjects below the age group of 10 and above the age of 60 years.
Patients suffering from from other concomitant disorders like Dermatophytes,Eczema ,Seborrhic Dermatitis,Pityriasis Rosea.
Patients with systemic diseases like diabetes,malignancy.
patients who refuse to give written consent for the study.
pregnant and lactating women.
any of them not covered under inclusion criteria.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method relief in signs and symptoms of psoriasisTimepoint: 6-12 Weeks.
- Secondary Outcome Measures
Name Time Method not applicableTimepoint: not applicable